|
CytRx reports $0.4M net income for 2010 vs. $4.8M net loss for 2009
CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the 12 months ended December 31, 2010, and provided a business update.
More... |
| All times are GMT -7. The time now is 07:56 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021